JP2021520196A5 - - Google Patents

Info

Publication number
JP2021520196A5
JP2021520196A5 JP2020554102A JP2020554102A JP2021520196A5 JP 2021520196 A5 JP2021520196 A5 JP 2021520196A5 JP 2020554102 A JP2020554102 A JP 2020554102A JP 2020554102 A JP2020554102 A JP 2020554102A JP 2021520196 A5 JP2021520196 A5 JP 2021520196A5
Authority
JP
Japan
Prior art keywords
adeno
associated virus
avv
muscular dystrophy
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020554102A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021520196A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/025496 external-priority patent/WO2019195362A1/en
Publication of JP2021520196A publication Critical patent/JP2021520196A/ja
Publication of JP2021520196A5 publication Critical patent/JP2021520196A5/ja
Pending legal-status Critical Current

Links

JP2020554102A 2018-04-03 2019-04-03 ジストロフィン異常症(dystrophinopathy)治療のためのヒンジ1および/または4の改変ジストロフィン Pending JP2021520196A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862651772P 2018-04-03 2018-04-03
US62/651,772 2018-04-03
PCT/US2019/025496 WO2019195362A1 (en) 2018-04-03 2019-04-03 Hinges 1 and/or 4 modified dystrophins for dystrophinopathy therapy

Publications (2)

Publication Number Publication Date
JP2021520196A JP2021520196A (ja) 2021-08-19
JP2021520196A5 true JP2021520196A5 (enExample) 2022-04-05

Family

ID=68101401

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020554102A Pending JP2021520196A (ja) 2018-04-03 2019-04-03 ジストロフィン異常症(dystrophinopathy)治療のためのヒンジ1および/または4の改変ジストロフィン

Country Status (5)

Country Link
US (1) US20210139550A1 (enExample)
EP (1) EP3773605A4 (enExample)
JP (1) JP2021520196A (enExample)
CN (1) CN111971050A (enExample)
WO (1) WO2019195362A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108463211B (zh) 2015-11-16 2022-09-27 全国儿童医院研究所 用于治疗肌联蛋白类肌病和其它肌联蛋白病变的材料和方法
US11338045B2 (en) 2017-03-17 2022-05-24 Newcastle University Adeno-associated virus vector delivery of a fragment of micro-dystrophin to treat muscular dystrophy
AU2019216257B2 (en) 2018-01-31 2025-11-20 Research Institute At Nationwide Children's Hospital Gene therapy for limb-girdle muscular dystrophy type 2C
IL324506A (en) 2018-06-18 2026-01-01 Res Inst Nationwide Childrens Hospital Adeno-associated virus vector for delivery of muscle-specific microdystrophin for the treatment of muscular dystrophy
IL279789B2 (en) 2018-06-29 2026-04-01 Res Inst Nationwide Childrens Hospital Recombinant adeno-associated virus products and methods for treating limb girdle muscular dystrophy 2A
CN113613668A (zh) 2018-10-24 2021-11-05 百时美施贵宝公司 小型化肌营养不良蛋白及其用途
KR20210133242A (ko) 2019-02-26 2021-11-05 더 리서치 인스티튜트 앳 네이션와이드 칠드런스 하스피탈 B-사르코글리칸의 아데노 관련 바이러스 벡터 전달 및 근이영양증의 치료
CA3150964A1 (en) 2019-08-21 2021-02-25 Research Institute At Nationwide Children's Hospital Adeno-associated virus vector delivery of alpha-sarcoglycan and the treatment of muscular dystrophy
AU2020392243A1 (en) 2019-11-28 2022-06-16 Regenxbio Inc. Microdystrophin gene therapy constructs and uses thereof
US11535868B2 (en) * 2020-04-29 2022-12-27 Bristol-Myers Squibb Company Miniaturized dystrophins having spectrin fusion domains and uses thereof
EP4164668A1 (en) 2020-06-15 2023-04-19 Research Institute at Nationwide Children's Hospital Adeno-associated virus vector delivery for muscular dystrophies
WO2022029543A1 (en) * 2020-08-06 2022-02-10 Intas Pharmaceuticals Ltd. Adeno-associated virus vector delivery of micro-dystrophin to treat muscular dystrophy
EP4108263A3 (en) 2021-06-02 2023-03-22 Research Institute at Nationwide Children's Hospital Recombinant adeno-associated virus products and methods for treating limb girdle muscular dystrophy 2a
US12285497B2 (en) 2021-10-15 2025-04-29 Research Institute At Nationwide Children's Hospital Self-complementary adeno-associated virus vector and its use in treatment of muscular dystrophy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7771993B2 (en) * 2004-01-23 2010-08-10 The Trustees Of The University Of Pennsylvania Microutrophin and uses thereof
US9624282B2 (en) * 2012-11-26 2017-04-18 The Curators Of The University Of Missouri Microdystrophin peptides and methods for treating muscular dystrophy using the same
WO2017223128A1 (en) * 2016-06-21 2017-12-28 The Curators Of The University Of Missouri Modified dystrophin proteins

Similar Documents

Publication Publication Date Title
JP2024054426A5 (enExample)
JP2026027271A5 (enExample)
JP2023002555A5 (enExample)
Zengel et al. Structural and cellular biology of adeno-associated virus attachment and entry
WO2019169004A8 (en) Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor
RU2019100525A (ru) Векторная система на основе аденоассоциированного вируса
JP2021513866A5 (enExample)
JP2019513393A5 (enExample)
JP2022501055A5 (enExample)
JP2008509695A5 (ja) 欠失可能なドメインタンパク質をコードする遺伝子におけるエクソンスキッピングのためのアデノ随伴ウイルスベクター
JP2019506445A5 (enExample)
JP2010516252A5 (enExample)
JP2022500066A5 (enExample)
JP2019522461A5 (enExample)
JP2017512466A5 (enExample)
Gilbert et al. Dystrophin expression in muscle following gene transfer with a fully deleted (" gutted") adenovirus is markedly improved by trans-acting adenoviral gene products
JP2018509154A5 (enExample)
JP7853958B2 (ja) 組み換えaavの作製方法
JP2017529395A5 (enExample)
JP2022551739A5 (enExample)
JP2021534796A5 (enExample)
JP2022535412A5 (enExample)
JP2024119830A5 (enExample)
JP2018533976A5 (enExample)
JP2022522756A5 (enExample)